Graduate Program in Genes and Development, University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX, USA; Department of Genetics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Evol Dev. 2014 Jul-Aug;16(4):207-23. doi: 10.1111/ede.12084. Epub 2014 Jun 11.
Transcriptional enhancers are genomic sequences bound by transcription factors that act together with basal transcriptional machinery to regulate gene transcription. Several high-throughput methods have generated large datasets of tissue-specific enhancer sequences with putative roles in developmental processes. However, few enhancers have been deleted from the genome to determine their roles in development. To understand the roles of two enhancers active in the mouse embryonic limb bud we deleted them from the genome. Although the genes regulated by these enhancers are unknown, they were selected because they were identified in a screen for putative limb bud-specific enhancers associated with p300, an acetyltransferase that participates in protein complexes that promote active transcription, and because the orthologous human enhancers (H1442 and H280) drive distinct lacZ expression patterns in limb buds of embryonic day (E) 11.5 transgenic mice. We show that the orthologous mouse sequences, M1442 and M280, regulate dynamic expression in the developing limb. Although significant transcriptional differences in enhancer-proximal genes in embryonic limb buds accompany the deletion of M1442 and M280 no gross limb malformations during embryonic development were observed, demonstrating that M1442 and M280 are not required for mouse limb development. However, M280 is required for the development and/or maintenance of body size; M280 mice are significantly smaller than controls. M280 also harbors an "ultraconserved" sequence that is identical between human, rat, and mouse. This is the first report of a phenotype resulting from the deletion of an ultraconserved element. These studies highlight the importance of determining enhancer regulatory function by experiments that manipulate them in situ and suggest that some of an enhancer's regulatory capacities may be developmentally tolerated rather than developmentally required.
转录增强子是基因组序列,与转录因子结合,共同作用于基础转录机制,调节基因转录。几种高通量方法已经生成了大量组织特异性增强子序列数据集,这些序列可能在发育过程中发挥作用。然而,很少有增强子从基因组中删除,以确定它们在发育中的作用。为了了解在小鼠胚胎肢芽中活跃的两个增强子的作用,我们从基因组中删除了它们。尽管这些增强子调控的基因未知,但它们被选中是因为它们在一个筛选中被鉴定为与 p300 相关的潜在肢芽特异性增强子,p300 是一种乙酰转移酶,参与促进活跃转录的蛋白质复合物,并且因为同源人类增强子 (H1442 和 H280) 在胚胎第 11.5 天的转基因小鼠的肢芽中驱动不同的 lacZ 表达模式。我们表明,同源小鼠序列 M1442 和 M280 调节发育中的肢体的动态表达。尽管 M1442 和 M280 的缺失伴随着胚胎肢芽中增强子近端基因的显著转录差异,但在胚胎发育过程中没有观察到明显的肢体畸形,这表明 M1442 和 M280 不是小鼠肢体发育所必需的。然而,M280 是身体大小的发育和/或维持所必需的;M280 小鼠明显比对照小鼠小。M280 还含有一个“超保守”序列,在人类、大鼠和小鼠之间完全相同。这是首次报道由于删除超保守元件而导致表型的报告。这些研究强调了通过实验原位操纵它们来确定增强子调节功能的重要性,并表明增强子的一些调节能力可能在发育上是可以容忍的,而不是必需的。